Acrivon Therapeutics, Inc. (ACRV)
2.10
+0.04
(+1.94%)
USD |
NASDAQ |
Aug 31, 16:00
2.05
-0.05
(-2.38%)
After-Hours: 17:40
Acrivon Therapeutics Price to Book Value : 1.038 for Aug. 31, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 1.018 |
| August 27, 2026 | 1.063 |
| August 26, 2026 | 1.028 |
| August 25, 2026 | 1.078 |
| August 24, 2026 | 1.088 |
| August 21, 2026 | 1.093 |
| August 20, 2026 | 1.088 |
| August 19, 2026 | 1.182 |
| August 18, 2026 | 1.014 |
| August 17, 2026 | 1.014 |
| August 14, 2026 | 0.9641 |
| August 13, 2026 | 0.9146 |
| August 12, 2026 | 0.8504 |
| August 11, 2026 | 0.8553 |
| August 10, 2026 | 0.8603 |
| August 07, 2026 | 0.8553 |
| August 06, 2026 | 0.8355 |
| August 05, 2026 | 0.8108 |
| August 04, 2026 | 0.7713 |
| August 03, 2026 | 0.7713 |
| July 31, 2026 | 0.7416 |
| July 30, 2026 | 0.7515 |
| July 29, 2026 | 0.707 |
| July 28, 2026 | 0.7614 |
| July 27, 2026 | 0.7713 |
| Date | Value |
|---|---|
| July 24, 2026 | 0.791 |
| July 23, 2026 | 0.8256 |
| July 22, 2026 | 0.8306 |
| July 21, 2026 | 0.8652 |
| July 20, 2026 | 0.8603 |
| July 17, 2026 | 0.8652 |
| July 16, 2026 | 0.8652 |
| July 15, 2026 | 0.9492 |
| July 14, 2026 | 1.053 |
| July 13, 2026 | 0.9789 |
| July 10, 2026 | 0.969 |
| July 09, 2026 | 1.014 |
| July 08, 2026 | 1.009 |
| July 07, 2026 | 0.9196 |
| July 06, 2026 | 0.88 |
| July 02, 2026 | 0.8504 |
| July 01, 2026 | 0.8553 |
| June 30, 2026 | 0.88 |
| June 29, 2026 | 0.722 |
| June 26, 2026 | 0.6815 |
| June 25, 2026 | 0.6409 |
| June 24, 2026 | 0.6571 |
| June 23, 2026 | 0.6612 |
| June 22, 2026 | 0.6409 |
| June 18, 2026 | 0.6369 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.809 |
| Alnylam Pharmaceuticals, Inc. | 23.77 |
| Anika Therapeutics, Inc. | 2.012 |
| Savara, Inc. | 7.706 |
| Vericel Corp. | 5.516 |
Price to Book Value Related Metrics
| Price | 2.10 |
| Earnings Yield | -89.76% |
| Market Cap | 89.98M |